ABAS Software Assesses Anatomy Boundaries
A new solution which estimates anatomy boundary contours (pdf) from CMS, Incorporated was cleared for marketing by the Food and Drug Administration. The Atlas-Based Autosegmentation (ABAS) product is now indicated for clinical use across the country.
ABAS estimates anatomy boundary contours required for development of a radiation treatment plan. This new application streamlines workflow by minimizing the time required to create and edit patient contours. This minimizes work because it provides clinicians with a starting point that requires minimal editing.
The system is also considered different from other boundary products that already cleared for marketing. Unique features incorporated include a stand-alone product that is vendor neutral. The solution communicates through common DICOM file formats for both data input and output.
The ABAS system can be used with any radiation treatment planning system available on the market equipped to evaluate DICOM RT structure set files. The tool further creates algorithms for structure specific refinement of both prostate and head and neck treatments. An included algorithm also allows use of the ABAS tool with other sites.
CMS is a company of Elekta. The company develops radiation treatment planning tools, as well as solutions to support workflow management in that setting. The company creates such by integrating innovative software applications along with newly created technology tools.
August 25, 2008 Related topics: Radiation Oncology, Product Approval & Certification, New Technology & Innovation, Diagnostic, IT & software